Bfsg LLC cut its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 1.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 82,087 shares of the company’s stock after selling 1,002 shares during the quarter. Colgate-Palmolive makes up 0.9% of Bfsg LLC’s holdings, making the stock its 27th biggest holding. Bfsg LLC’s holdings in Colgate-Palmolive were worth $7,463,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Kestra Investment Management LLC grew its stake in Colgate-Palmolive by 57.6% during the fourth quarter. Kestra Investment Management LLC now owns 16,379 shares of the company’s stock worth $1,489,000 after purchasing an additional 5,984 shares during the period. Braun Stacey Associates Inc. lifted its position in Colgate-Palmolive by 8.7% in the 4th quarter. Braun Stacey Associates Inc. now owns 250,787 shares of the company’s stock valued at $22,799,000 after acquiring an additional 19,967 shares in the last quarter. Kornitzer Capital Management Inc. KS boosted its position in shares of Colgate-Palmolive by 3.0% during the fourth quarter. Kornitzer Capital Management Inc. KS now owns 109,690 shares of the company’s stock valued at $9,972,000 after buying an additional 3,145 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Colgate-Palmolive by 427.9% during the 4th quarter. Venturi Wealth Management LLC now owns 22,728 shares of the company’s stock worth $2,066,000 after acquiring an additional 18,423 shares during the last quarter. Finally, CIBC Asset Management Inc grew its position in Colgate-Palmolive by 2.0% in the 4th quarter. CIBC Asset Management Inc now owns 193,309 shares of the company’s stock worth $17,559,000 after purchasing an additional 3,784 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.
Colgate-Palmolive Trading Down 1.9 %
NYSE CL opened at $86.10 on Tuesday. The firm has a market cap of $70.34 billion, a price-to-earnings ratio of 24.46, a PEG ratio of 4.12 and a beta of 0.44. The firm has a 50 day simple moving average of $89.53 and a 200-day simple moving average of $96.33. Colgate-Palmolive has a one year low of $83.20 and a one year high of $109.30. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.26 and a current ratio of 0.41.
Colgate-Palmolive Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.32%. The ex-dividend date was Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.82%.
Analyst Ratings Changes
A number of analysts recently issued reports on CL shares. Raymond James restated an “outperform” rating and set a $105.00 price objective (down previously from $110.00) on shares of Colgate-Palmolive in a report on Monday, February 3rd. TD Cowen dropped their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. StockNews.com downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a report on Friday, January 17th. Finally, Morgan Stanley reduced their price objective on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. One analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $101.16.
Get Our Latest Research Report on CL
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Recommended Stories
- Five stocks we like better than Colgate-Palmolive
- What Do S&P 500 Stocks Tell Investors About the Market?
- Airbnb’s Earnings: Sky High Results, Grounded Guidance?
- The Basics of Support and Resistance
- Kyndryl Soars on AI, Cybersecurity Growth—What’s Next?
- Pros And Cons Of Monthly Dividend Stocks
- Conflicting Signals: Tempus AI’s Stock Market Rally
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.